525,00 €
AA 1-419 from SARS-CoV-2 Nucleocapsid protein (UniProt ID: P0DTC9) fused to a c-terminal polyhistidine tag
AA 1-419 from SARS-CoV-2 Nucleocapsid protein (UniProt ID: P0DTC9) fused to a c-terminal polyhistidine tag
Variations: |
|
||||||||
---|---|---|---|---|---|---|---|---|---|
Related Products: | - | ||||||||
Clone: | - | ||||||||
Host: | - | ||||||||
Produced in: | E. coli | ||||||||
Application: | IP, WB | ||||||||
Dilution: | - | ||||||||
Capacity: | - | ||||||||
Antigen: | - | ||||||||
Targets: | - | ||||||||
Specificity: | - | ||||||||
Formulation: | 1 mg lyophilized from 330 µL phosphate buffer pH 6.0, 300 mM NaCl, 1 mM EDTA. For reconstitution add 330 µl H2O, then aliquot and store at -20°C until use. | ||||||||
kDa: | 46.4 kDa | ||||||||
Ext Coef: | 43890 | ||||||||
Shipping: | Ambiant temperature | ||||||||
Storing: | Lyophilized vials can be stored at 4 °C for upto 6 months. Reconstituted vials should be stored at - 20 °C or below. | ||||||||
Protocols: | - | ||||||||
References: | - | ||||||||
Notice: | To be used in vitro/ for research only. Non-toxic, non-hazardous, non-infectious. | ||||||||
Legal terms: | By purchasing this product you agree to our general terms and conditions. |